Resectable Pancreatic Cancer Debate: Total Neoadjuvant vs Adjuvant Therapy - Total Neoadjuvant
Earn CME: https://www.naccme.com/program/20-gdugi-03
© 2021 NACCME, an HMP Company
Видео Resectable Pancreatic Cancer Debate: Total Neoadjuvant vs Adjuvant Therapy - Total Neoadjuvant канала ImedexCME
© 2021 NACCME, an HMP Company
Видео Resectable Pancreatic Cancer Debate: Total Neoadjuvant vs Adjuvant Therapy - Total Neoadjuvant канала ImedexCME
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Resectable Pancreatic Cancer Debate: Total Neoadjuvant vs Adjuvant Therapy - Adjuvant Therapy
Debate: How to treat borderline, resectable pancreatic cancer? - Chemotherapy alone
Rectal cancer after neoadjuvant therapy with complete clinical response - Surgery
Debate: Treatment for Resectable Pancreatic Cancer? - Neo-Adjuvant Chemotherapy
BRCA+ Pancreatic Cancer Maintenance Debate: PARP Inhibitor or Continued Chemo? - Cont'd Chemotherapy
Current and Future Directions in Metastatic Pancreatic Cancer
Treatment Advances: The Latest in Pancreatic Cancer Clinical Research
Surviving Pancreatic Cancer
Is pancreatic cancer a death sentence?
Accelerated pancreatic cancer trials
Treat-to-Target in IBD: Decreasing Inflammation & Achieving Mucosal Healing
Pancreatic Cancer
Current controversies in Small Cell Lung Cancer (SCLC)
BRCA+ Pancreatic Cancer Maintenance Debate: PARP Inhibitor or Continued Chemo? - PARP Inhibitor
ICAHO20 - ASCO Direct™ Highlights - Dr. Andrew Coveler - Pancreatic Cancer
Advances in Anti Cytokine Therapy: Mechanisms of Action and Efficacy
Apple Event — April 20
Basics of Immunotherapy in Small Cell Lung Cancer (SCLC)
Novel Solutions, Personalized Treatment: The Rectal Cancer Multidisciplinary Clinic Webinar
Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers